Low-dose recombinant interferon-α in the treatment of cutaneous T-cell lympbomas
- 1 October 1989
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 121 (4) , 543-544
- https://doi.org/10.1111/j.1365-2133.1989.tb15526.x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Treatment of mycosis fungoides with recombinant interferon-αza2 alone and in combination with etretinateBritish Journal of Dermatology, 1988
- Low dosage alpha‐interferon treatment in patients with advanced cutaneous T‐cell lymphomaEuropean Journal of Haematology, 1988
- Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapyArchives of Dermatology, 1987
- Low doses of interferon alpha result in more effective clinical natural killer cell activation.Journal of Clinical Investigation, 1985
- Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complexCell, 1982